Joel Michael Maryles - Mar 18, 2022 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role
Director
Signature
/s/ Matthew Rudolph, Esq., Attorney-in-Fact for Joel Michael Maryles
Stock symbol
CMMB
Transactions as of
Mar 18, 2022
Transactions value $
$4,340
Form type
4
Date filed
3/21/2022, 06:04 AM
Previous filing
Mar 9, 2022
Next filing
May 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMMB American Depositary Shares Purchase $2.16K +500 $4.32 500 Mar 18, 2022 Direct F1
transaction CMMB American Depositary Shares Purchase $2.18K +500 +100% $4.36 1K Mar 18, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMMB Option to Purchase American Depositary Shares Award $0 +6.82K $0.00 6.82K Mar 7, 2022 American Depositary Shares 6.82K $3.53 Direct F1, F2, F3
transaction CMMB Option to Purchase American Depositary Shares Award $0 +11.9K $0.00 11.9K Apr 19, 2021 American Depositary Shares 11.9K $27.26 Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F2 No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F3 These options vest and become exercisable in their entirety on March 16, 2023.
F4 These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.